Deepak R

128 posts

Deepak R

Deepak R

@drdippi

参加日 Mart 2013
356 フォロー中97 フォロワー
AI Highlight
AI Highlight@AIHighlight·
Claude is the smartest Al right now. But 90% of people prompt it like ChatGPT. That's why I made the Claude Mastery Guide: → How Claude thinks differently → Prompts built for Claude → 2000+ Al Prompts Comment "Claude" and I'll DM it free.
AI Highlight tweet media
English
2.4K
226
2.5K
297.8K
Deepak R がリツイート
Boris Sobolev
Boris Sobolev@soboleffspaces·
The real (and exciting) reason this paper caught my attention is its eloquent discussion of the RCT transportability problem. The author argues that while some trials in critical care may be internally valid (thanks to randomization), their results cannot be reliably applied (transported) to future patients, other hospitals, or subsequent trials. In the causality literature, transportability was rigorously treated by @yudapearl and @eliasbareinboim. But seeing it articulated so clearly in clinical discourse—“non-transportability means results from an RCT cannot reliably apply to your next patient”—had a real Christmas-came-early vibe. The article argues that non-transportability arises because enrollment criteria lump together distinct diseases, such as viral and bacterial pneumonia. The reported treatment effect is therefore a weighted average over a mixed-disease population. If the patient mix changes across hospitals or populations, the average treatment effect estimated by an RCT changes too. True, randomization guarantees internal balance, but the findings remain unhelpful for real-world critical care. By averaging opposing biological responses, trials can mask how treatment might save a bacterial patient while harming a viral one. Strong words. Takes guts.
Boris Sobolev@soboleffspaces

A seminal paper dismantling 50 years of critical care dogma and RCTs failing patients @PatientStormDoc publishes a historical review revealing that decades of critical care trials for sepsis and ARDS rely on the flawed "Petty-Bone" design, which substitutes synthetic, threshold-based syndromes for distinct biological diseases. Using Causal Symbolic Modeling and Directed Acyclic Graphs, the author demonstrates that these synthetic surrogates function as cohort colliders, mixing incompatible pathologies like viral and bacterial pneumonia into unstable groups. This conceptual error renders trial results non-transportable, explaining replication crisis in critical care RCTs and high-profile reversals after causing patient harm. The study exposes how international task forces have perpetuated a "pathological consensus" by recycling arbitrary surrogates rather than addressing the fundamental lack of causal validity in their designs. The author argues we must abandon the Petty-Bone RCT framework immediately to end this era of "science mimicry"—and mandate causal modeling in all future grant-funded research and CONSORT guidelines. pmc.ncbi.nlm.nih.gov/articles/PMC12…

English
5
12
36
9.8K
Think In Points
Think In Points@think_in_points·
I’ve applied for Schengen Visas multiple times, and got all of them delivered within 6 working days! I’ve cracked a process that works for the salaried class. I have even built a detailed checklist + cover letter template. It helped my colleagues, and I want to help others. 🧵
Think In Points tweet media
English
524
38
476
83.3K
Deepak R がリツイート
Critical Care Reviews
Critical Care Reviews@CritCareReviews·
How we use critical care ultrasonography in the management of cardiogenic shock: a strategic game of chess in intensive care CCR Journal Watch - tracking the critical care literature daily criticalcarereviews.com/latest-evidenc…
Critical Care Reviews tweet media
English
1
52
163
12.1K
Deepak R がリツイート
RCHPediatrics
RCHPediatrics@RchPediatrics·
Congratulations to Devika on securing first prize poster presentation in World ARDS meet Delhi!It's an achievement & acknowledgement of our collective effort of antivirals and immunomodulation therapy in Adenoviral ARDS @rakshay_shetty @bhat_chandrika @Manu_Delhi87 @DrPavitraV
RCHPediatrics tweet mediaRCHPediatrics tweet media
English
0
3
10
1.2K
Deepak R がリツイート
RCHPediatrics
RCHPediatrics@RchPediatrics·
Join us for an electrifying Cytokine Storm Symposium!Dive into cutting-edge insights with Dr. Randy Cron as he unravels "Personalized Approaches to Treating Secondary CSS." Don’t miss this chance to learn from a global expert! Register now! abhinavaglobalacademy.com/crs-registrati…
English
1
1
2
928
Deepak R がリツイート
RCHPediatrics
RCHPediatrics@RchPediatrics·
Speaker Spotlight! Dr. Shanmuganathan Chandrakasan—immunology expert & Director of Immune Dysregulation at Emory—joins our #CytokineStorm symposium! He'll expose how PIDs can masquerade as cytokine storms 🔥🧬 Don’t miss this eye-opening session! abhinavaglobalacademy.com/crs-registrati…
RCHPediatrics tweet media
English
1
1
3
123
Deepak R がリツイート
RCHPediatrics
RCHPediatrics@RchPediatrics·
Dr. A.V. Ramanan just delivered a powerful session on ‘Hyperferritinemia in Sepsis: When to Immunomodulate?’ at the Cytokine Storm Symposium — expert insights into timing, thresholds, and therapeutic windows. A masterclass in managing immune chaos!
RCHPediatrics tweet mediaRCHPediatrics tweet mediaRCHPediatrics tweet mediaRCHPediatrics tweet media
English
1
6
13
710
Deepak R がリツイート
RCHPediatrics
RCHPediatrics@RchPediatrics·
Dr. Marco Gattorno delivers an insightful talk on “From Autoinflammation to Cytokine Storm: A Spectrum of Immune Dysregulation” at the Cytokine Storm Symposium — shedding light on the evolving landscape of hyperinflammatory responses @bhat_chandrika @mmdesai007 @TheIMIDForum
RCHPediatrics tweet mediaRCHPediatrics tweet mediaRCHPediatrics tweet mediaRCHPediatrics tweet media
English
2
4
9
263